Global Hemoglobin Testing Market Size To Exceed USD 5.41 Billion By 2033: Market Size Report

Global Hemoglobin Testing Market Size To Exceed USD 5.41 Billion By 2033

According to a research report published by Spherical Insights & Consulting, The Global Hemoglobin Testing Market Size is Expected to Grow from USD 2.70 Billion in 2023 to USD 5.41 Billion by 2033, Growing at a CAGR of 7.20% during the forecast period 2023-2033.

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Hemoglobin Testing Market Size, Share, and COVID-19 Impact Analysis, By Type (Instruments, Reagents & Consumables), By Technology (Spectrophotometer, Chromatography, Immunoassay, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

The worldwide haemoglobin testing devices market is described to businesses that assist the healthcare sector by manufacturing and providing tools or devices for reconciling and recognizing the level of hemoglobin in blood concentration. For the diagnosis and ongoing monitoring of blood disorders such as thalassemia, polycythemia, anemia, and others, the hemoglobin test is crucial. The main factors propelling the hemoglobin testing market's expansion are the increasing prevalence of hemoglobinopathies, the development of hemoglobin testing equipment, and the growing use of POCT devices. The need for sophisticated hemoglobin testing solutions is also driven by rising health consciousness and the focus on preventive healthcare, which promotes routine health examinations, including hemoglobin testing. However, the high cost of new devices could hamper widespread adoption.

The instruments segment dominated the global hemoglobin testing market in 2023 and is projected to grow at a substantial CAGR over the forecast period.

On the basis of the type, the global hemoglobin testing market is divided into instruments, reagents & consumables. Among these, the instruments segment dominated the global hemoglobin testing market in 2023 and is expected to grow at a substantial CAGR over the forecast period. This segment growth is driven by providing quick and precise hemoglobin measurements, as well as high demand due to the growing chronic illnesses like diabetes and chronic renal disease that necessitate routine hemoglobin monitoring.

The spectrophotometer held the largest market share of the global hemoglobin testing market in 2023 and is anticipated to grow at a substantial CAGR over the forecast period.

On the basis of the technology, the global hemoglobin testing market is differentiated into spectrophotometer, chromatography, immunoassay, and others. Among these, the spectrophotometer segment held the largest market share of the global hemoglobin testing market in 2023 and is anticipated to grow at a substantial CAGR over the forecast period. This segment growth is influenced by its superior accuracy, reliability, and versatility in measuring hemoglobin levels. Moreover, their great capacity to handle sample types makes these instruments perfect for use in diagnostic labs, clinics, and hospitals.

Asia Pacific is anticipated to hold the largest share of the global hemoglobin testing market over the forecast period.

Asia Pacific is estimated to hold the highest share of the global hemoglobin testing market over the forecast period. The regional market growth is driven by enhanced healthcare infrastructure with rising cases of common diseases, including anemia and other hemoglobin abnormalities. Furthermore, governmental health programs aimed at enhancing mother and child health are also propelling the use of hemoglobin testing devices market.

North America is expected to grow at the fastest CAGR of the global hemoglobin testing market over the forecast period. The regional market growth is accelerated because of its established key players, increasing solid technical improvements, and several public health programs and awareness efforts for hemoglobin disorders.

Company Profiling

Major vendors in the global hemoglobin testing market are Bio-Rad Laboratories, Inc., ACON Laboratories, Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Beckman Coulter, Inc. (Danaher Corporation), Thermo Fisher Scientific, Daiichi Biotech Services Sdn Bhd, MGC Diagnostics Corporation, DiaSys Diagnostic Systems, Sysmex Corporation, Erba Mannheim, EKF Diagnostics Holdings, ARKRAY, Inc., Sanguina Inc., and others.

Key Target Audience      

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development:

• In June 2023, the CSIR-Indian Institute of Toxicology Research (IITR) in Lucknow developed an innovative rapid haemoglobin testing kit called 'SenzHb'. This paper-based kit provided results in just 30 seconds and cost only RS 10 per test. It was designed to be user-friendly and accessible, making it ideal for remote and rural areas, and included a colorimetric strip-type sensor, and users could determine their haemoglobin levels by observing the color change.

Market Segment                                             

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global hemoglobin testing market based on the below-mentioned segments: 

Global Hemoglobin Testing Market, By Type

• Instruments
• Reagents & Consumables

Global Hemoglobin Testing Market, By Technology

• Spectrophotometer
• Chromatography
• Immunoassay
• Others

Global Hemoglobin Testing Market, By Regional

•  North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa